CHFW insider filings
Consonance-HFW Acquisition Corp. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-05-19. Screen CHFW transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CHFW between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Consonance-HFW Acquisition Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-05-19 | 4/A | Soffer Benny — Director | Grant/award (A): 24,000 · Grant/award (A): 8,000 (derivative) | EDGAR |
| 2021-05-19 | 4/A | Soffer Benny — Director | Grant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 more | EDGAR |
| 2021-05-19 | 4/A | Livingston Kevin Harold — Chief Financial Officer | Grant/award (A): 24,000 · Grant/award (A): 8,000 (derivative) | EDGAR |
| 2021-05-19 | 4/A | Livingston Kevin Harold — Chief Financial Officer | Grant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 more | EDGAR |
| 2021-05-19 | 4/A | Consonance Life Sciences — Director | Grant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 more | EDGAR |
| 2021-05-19 | 4/A | Consonance Life Sciences — Director, 10% owner | Grant/award (A): 24,000 · Grant/award (A): 8,000 (derivative) | EDGAR |
| 2021-05-19 | 4/A | BLUTT MITCHELL J MD — Director | Grant/award (A): 24,000 · Grant/award (A): 8,000 (derivative) | EDGAR |
| 2021-05-19 | 4/A | BLUTT MITCHELL J MD — Director | Grant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 more | EDGAR |
| 2020-12-04 | 4 | BLUTT MITCHELL J MD — Director, 10% owner Consonance Capital Management LP — Director, 10% owner Consonance Capital Opportunity Fund Management LP — Director, 10% owner Consonance Capman GP, LLC — Director, 10% owner | Purchase (P): 500,000 · Purchase (P): 371,100 · Purchase (P): 128,900 | EDGAR |
| 2020-12-03 | 4 | Soffer Benny — Director | Purchase (P): 24,000 · Purchase (P): 8,000 (derivative) | EDGAR |
| 2020-12-03 | 4 | Livingston Kevin Harold — Chief Financial Officer | Purchase (P): 24,000 · Purchase (P): 8,000 (derivative) | EDGAR |
| 2020-12-03 | 4 | Consonance Life Sciences — 10% owner | Purchase (P): 24,000 · Purchase (P): 8,000 (derivative) | EDGAR |
| 2020-12-03 | 4 | BLUTT MITCHELL J MD — Director | Purchase (P): 24,000 · Purchase (P): 8,000 (derivative) | EDGAR |
| 2020-11-25 | 4 | Livingston Kevin Harold — Chief Financial Officer | Purchase (P): 410,000 · Purchase (P): 136,667 (derivative) | EDGAR |
| 2020-11-25 | 4 | Soffer Benny — Director | Purchase (P): 410,000 · Purchase (P): 136,667 (derivative) | EDGAR |
| 2020-11-25 | 4 | Consonance Life Sciences — 10% owner | Purchase (P): 410,000 · Purchase (P): 136,667 (derivative) | EDGAR |
| 2020-11-25 | 4 | BLUTT MITCHELL J MD — Director | Purchase (P): 410,000 · Purchase (P): 136,667 (derivative) | EDGAR |
Recent 8-K events — Consonance-HFW Acquisition Corp.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-20 | 8-K | 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-05-14 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CHFW returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs